| Autor: |
Lim, Endry Hartono Taslim, van Amstel, Rombout Benjamin Ezra, de Boer, Vieve Victoria, van Vught, Lonneke Alette, de Bruin, Sanne, Brouwer, Matthijs Christian, Vlaar, Alexander Petrus Johannes, van de Beek, Diederik |
| Zdroj: |
Blood Reviews; Jan2023, Vol. 57, pN.PAG-N.PAG, 1p |
| Abstrakt: |
Increasing evidence suggests that activation of the complement system plays a key role in the pathogenesis and disease severity of Coronavirus disease 2019 (COVID-19). We used a systematic approach to create an overview of complement activation in COVID-19 based on histopathological, preclinical, multiomics, observational and clinical interventional studies. A total of 1801 articles from PubMed, EMBASE and Cochrane was screened of which 157 articles were included in this scoping review. Histopathological, preclinical, multiomics and observational studies showed apparent complement activation through all three complement pathways and a correlation with disease severity and mortality. The complement system was targeted at different levels in COVID-19, of which C5 and C5a inhibition seem most promising. Adequately powered, double blind RCTs are necessary in order to further investigate the effect of targeting the complement system in COVID-19. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
Full Text from ScienceDirect